Next Article in Journal
The Relevance of Caseous Lymphadenitis as a Cause of Culling in Adult Sheep
Next Article in Special Issue
Appeasing Pheromones for the Management of Stress and Aggression during Conservation of Wild Canids: Could the Solution Be Right under Our Nose?
Previous Article in Journal
The Development of a Novel Questionnaire Approach to the Investigation of Horse Training, Management, and Behaviour
Communication

Administering an Appeasing Substance to Gir × Holstein Female Dairy Calves on Pre-Weaning Performance and Disease Incidence

1
School of Veterinary Medicine and Animal Science, São Paulo State University (UNESP), Botucatu 18618-000, Brazil
2
Nutricorp, Araras 13601-000, Brazil
3
Department of Animal Science, Texas A&M University, College Station, TX 77845, USA
*
Author to whom correspondence should be addressed.
Animals 2020, 10(11), 1961; https://doi.org/10.3390/ani10111961
Received: 4 September 2020 / Revised: 22 September 2020 / Accepted: 29 September 2020 / Published: 24 October 2020
(This article belongs to the Special Issue Animal Behavior: Insights into Chemical Communication)
Stress is a common issue faced by ruminants throughout their productive lives, with significant effects on health and performance of the herd. Hence, strategies that alleviate stress-induced responses with a concomitant increase in performance and health are warranted. Administration of the bovine appeasing substance improved performance and reduced the costs related to pharmacological intervention of pre-weaning dairy calves. Therefore, the utilization of the bovine appeasing substance is a feasible alternative to improve health and performance of the dairy cattle herd.
(1) Background: Ruminants often face stressful situations throughout their productive lives. More specifically, pre-weaning dairy calves are exposed to novel environments, feedstuffs, and pathogens that affect their health and performance. Hence, alternatives that reduce stress and promote growth of pre-weaning dairy calves are warranted. Therefore, this study evaluated the effects of biweekly bovine appeasing substance (BAS) administration on performance and disease incidence in dairy Gir × Holstein female calves prior to weaning. (2) Methods: At birth, 140 female Gir × Holstein calves were randomly assigned to receive BAS (SecureCattle; (IRSEA Group, Quartier Salignan, France; n = 70) or placebo (BAS carrier, diethylene glycol monoethyl ether; CON; n = 70) biweekly until weaning (70 days of age). Calves were allocated into individual housing at random, with no physical contact between treatments to avoid cross-contamination. Experimental treatments (5 mL) were applied topically to the nuchal skin area of each calf. Throughout the experimental period, all animals were observed daily for medical conditions (diarrhea, pneumonia, and others), medical/pharmacological interventions were recorded, and the costs related to these procedures were analyzed. Concurrently with treatment application, calves were individually weighed, and data were analyzed using animal as the experimental unit. (3) Results: Treatment × day and treatment × period (14-day interval) interactions were observed for body weight (BW) and average daily gain (ADG; p ≤ 0.05), respectively. Calves receiving BAS had greater BW at weaning (p = 0.02) and tended to have a greater BW on day 56 (p = 0.06). Similarly, ADG was greater for BAS from days 42 to 56 (p = 0.04) and tended to be greater from days 56 to weaning (p = 0.10). No differences were observed on the overall occurrence of diseases (p = 0.92), whereas the most common observed diseases were diarrhea and pneumonia. The incidence and mean age at which animals were detected with these diseases did not differ (p ≥ 0.46). Nonetheless, CON calves detected with disease had a reduced ADG vs. BAS-administered counterparts (p < 0.01). No differences were observed between disease-diagnosed BAS vs. healthy CON, but healthy BAS had a greater ADG vs. healthy CON (p = 0.03). A treatment effect was observed for the cost per head of each pharmacological intervention (p = 0.05). (4) Conclusions: In summary, BAS administration at a 14-day interval improved performance and reduced the costs of pharmacological interventions of pre-weaning Gir × Holstein dairy calves. View Full-Text
Keywords: bovine appeasing substance; dairy calves; diarrhea; performance; pneumonia bovine appeasing substance; dairy calves; diarrhea; performance; pneumonia
Show Figures

Figure 1

MDPI and ACS Style

Angeli, B.; Cappellozza, B.; Moraes Vasconcelos, J.L.; Cooke, R.F. Administering an Appeasing Substance to Gir × Holstein Female Dairy Calves on Pre-Weaning Performance and Disease Incidence. Animals 2020, 10, 1961. https://doi.org/10.3390/ani10111961

AMA Style

Angeli B, Cappellozza B, Moraes Vasconcelos JL, Cooke RF. Administering an Appeasing Substance to Gir × Holstein Female Dairy Calves on Pre-Weaning Performance and Disease Incidence. Animals. 2020; 10(11):1961. https://doi.org/10.3390/ani10111961

Chicago/Turabian Style

Angeli, Beatriz, Bruno Cappellozza, José L. Moraes Vasconcelos, and Reinaldo F. Cooke 2020. "Administering an Appeasing Substance to Gir × Holstein Female Dairy Calves on Pre-Weaning Performance and Disease Incidence" Animals 10, no. 11: 1961. https://doi.org/10.3390/ani10111961

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop